Latest / Applied Clinical Trials
ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA
In today’s ACT Brief, we look at new insights on strategy-driven clinical development, fresh survey data revealing persistent site startup delays, and major leadership turnover inside FDA’s drug division.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.